Skip to main content
. 2022 May 11;298(7):102025. doi: 10.1016/j.jbc.2022.102025

Table 3.

Experimental data

PS level
14%
14.39%
16.52%
20%
30%
Experimental conditions PSA-3 (genetic PS deficient) HEK293 treated with 5 μM fendiline HEK293 treated with 1 μM fendiline HEK293 (WT) PSA-3 supplied with additional PS
Oligomer ratio (24 h)
VLP production (24 h)
Relative oligomer frequency (24 h)
Relative VLP production (24 h)
Relative VLP production (48 h)
VP40 budding ratio (48 h)